BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21832820)

  • 1. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
    Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
    Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.
    Qi P; Ruan CP; Wang H; Zhou FG; Xu XY; Gu X; Zhao YP; Dou TH; Gao CF
    Int J Colorectal Dis; 2010 Jan; 25(1):39-45. PubMed ID: 19787358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.
    Jin P; Xiang B; Huang G; Zhou Z
    J Endocrinol Invest; 2015 Feb; 38(2):149-54. PubMed ID: 25185645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the CTLA-4 +49A/G polymorphism with rheumatoid arthritis in Chinese Han population.
    Tang MJ; Zhou ZB
    Mol Biol Rep; 2013 Mar; 40(3):2627-31. PubMed ID: 23264071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.
    Wang L; Su G; Zhao X; Cai Y; Cai X; Zhang J; Liu J; Wang T; Wang J
    Tumour Biol; 2014 Feb; 35(2):1139-42. PubMed ID: 24014088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.
    Kimkong I; Nakkuntod J; Sae-Ngow S; Snabboon T; Avihingsanon Y; Hirankarn N
    Asian Pac J Allergy Immunol; 2011 Sep; 29(3):229-35. PubMed ID: 22053592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R; Erken E; Dinkci S
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism is associated with increased risk of osteosarcoma.
    Wang W; Wang J; Song H; Liu J; Song B; Cao X
    Genet Test Mol Biomarkers; 2011; 15(7-8):503-6. PubMed ID: 21453059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
    Duan S; Zhang G; Han Q; Li Z; Liu Z; Chen J; Lv Y; Li N; Wang Y; Li M; Lou S; Yang M; Zhu Q; Xing F
    Mol Biol Rep; 2011 Nov; 38(8):5125-32. PubMed ID: 21161390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
    Budak Diler S; Yaraş S
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):97-101. PubMed ID: 30213296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
    Chang WW; Zhang L; Yao YS; Su H
    Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma.
    Yang S; Wang C; Zhou Y; Sun G; Zhu D; Gao S
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1236-40. PubMed ID: 22905924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(6):7421-5. PubMed ID: 26261646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.
    Antczak A; Pastuszak-Lewandoska D; Górski P; Domańska D; Migdalska-Sęk M; Czarnecka K; Nawrot E; Kordiak J; Brzeziańska E
    Biomed Res Int; 2013; 2013():576486. PubMed ID: 23936819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 +49A/G Polymorphism Increases the Susceptibility to Bladder Cancer in Chinese Han Participants: A Case-Control Study.
    Mao F; Niu XB; Gu S; Ji L; Wei BJ; Wang HB
    Dis Markers; 2020; 2020():8143158. PubMed ID: 33335608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A/G polymorphism at position 49 in exon 1 of CTLA-4 gene in Chinese women with unexplained recurrent spontaneous abortion].
    Wang XP; Lin QD; Ma ZW; Hong Y; Zhao AM; Di W; Lu PH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):155-8. PubMed ID: 16640877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
    Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
    Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.
    Jaiswal PK; Singh V; Mittal RD
    Mol Biol Rep; 2014 Feb; 41(2):799-807. PubMed ID: 24390231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis.
    Wei Z; Zhang S; Hu J
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):173-181. PubMed ID: 33819967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.